Anixa Historical Income Statement

ANIX Stock  USD 3.32  0.10  3.11%   
Historical analysis of Anixa Biosciences income statement accounts such as Selling General Administrative of 4.2 M, Total Revenue of 229.4 K or Gross Profit of 53.5 K can show how well Anixa Biosciences performed in making a profits. Evaluating Anixa Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Anixa Biosciences's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Anixa Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anixa Biosciences is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

About Anixa Income Statement Analysis

Anixa Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Anixa Biosciences shareholders. The income statement also shows Anixa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Anixa Biosciences Income Statement Chart

At this time, Anixa Biosciences' Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Anixa Biosciences minus its cost of goods sold. It is profit before Anixa Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anixa Biosciences. It is also known as Anixa Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.
Most accounts from Anixa Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.

Anixa Biosciences income statement Correlations

0.21-0.13-0.13-0.230.380.380.38-0.340.120.510.040.11-0.63-0.690.410.21-0.610.220.0-0.38-0.390.37
0.210.260.260.85-0.65-0.65-0.650.81-0.73-0.19-0.08-0.74-0.190.440.18-0.62-0.220.240.040.30.28-0.35
-0.130.261.00.33-0.36-0.37-0.380.37-0.34-0.26-0.19-0.340.050.39-0.14-0.360.05-0.04-0.18-0.080.03-0.34
-0.130.261.00.33-0.36-0.37-0.380.37-0.34-0.26-0.19-0.340.050.39-0.14-0.360.06-0.05-0.18-0.080.03-0.34
-0.230.850.330.33-0.8-0.79-0.780.97-0.78-0.520.09-0.790.00.740.15-0.66-0.010.32-0.060.390.4-0.43
0.38-0.65-0.36-0.36-0.81.01.0-0.910.940.480.020.94-0.2-0.890.420.89-0.150.20.06-0.5-0.540.55
0.38-0.65-0.37-0.37-0.791.01.0-0.90.940.50.040.94-0.22-0.880.430.88-0.150.220.04-0.53-0.550.58
0.38-0.65-0.38-0.38-0.781.01.0-0.90.930.50.090.94-0.23-0.880.450.88-0.150.240.02-0.55-0.570.61
-0.340.810.370.370.97-0.91-0.9-0.9-0.85-0.540.03-0.860.120.85-0.11-0.760.090.07-0.070.450.47-0.5
0.12-0.73-0.34-0.34-0.780.940.940.93-0.850.31-0.031.00.12-0.760.290.930.150.110.11-0.38-0.40.42
0.51-0.19-0.26-0.26-0.520.480.50.5-0.540.310.060.33-0.48-0.490.070.09-0.42-0.11-0.11-0.53-0.520.56
0.04-0.08-0.19-0.190.090.020.040.090.03-0.030.06-0.02-0.22-0.020.230.03-0.010.26-0.42-0.37-0.250.62
0.11-0.74-0.34-0.34-0.790.940.940.94-0.861.00.33-0.020.11-0.760.280.930.150.10.11-0.38-0.40.43
-0.63-0.190.050.050.0-0.2-0.22-0.230.120.12-0.48-0.220.110.31-0.470.10.89-0.360.310.480.53-0.46
-0.690.440.390.390.74-0.89-0.88-0.880.85-0.76-0.49-0.02-0.760.31-0.41-0.810.24-0.17-0.030.520.56-0.56
0.410.18-0.14-0.140.150.420.430.45-0.110.290.070.230.28-0.47-0.410.39-0.410.95-0.01-0.26-0.280.28
0.21-0.62-0.36-0.36-0.660.890.880.88-0.760.930.090.030.930.1-0.810.390.150.220.11-0.35-0.360.4
-0.61-0.220.050.06-0.01-0.15-0.15-0.150.090.15-0.42-0.010.150.890.24-0.410.15-0.35-0.090.160.17-0.15
0.220.24-0.04-0.050.320.20.220.240.070.11-0.110.260.1-0.36-0.170.950.22-0.350.06-0.09-0.050.09
0.00.04-0.18-0.18-0.060.060.040.02-0.070.11-0.11-0.420.110.31-0.03-0.010.11-0.090.060.580.75-0.46
-0.380.3-0.08-0.080.39-0.5-0.53-0.550.45-0.38-0.53-0.37-0.380.480.52-0.26-0.350.16-0.090.580.85-0.84
-0.390.280.030.030.4-0.54-0.55-0.570.47-0.4-0.52-0.25-0.40.530.56-0.28-0.360.17-0.050.750.85-0.76
0.37-0.35-0.34-0.34-0.430.550.580.61-0.50.420.560.620.43-0.46-0.560.280.4-0.150.09-0.46-0.84-0.76
Click cells to compare fundamentals

Anixa Biosciences Account Relationship Matchups

Anixa Biosciences income statement Accounts

201920202021202220232024 (projected)
Selling General Administrative5.6M7.1M7.2M6.3M7.2M4.2M
Total Revenue0.0512.5K2.5B210K241.5K229.4K
Gross Profit(90.2K)127.5K2.5B49K56.4K53.5K
Other Operating Expenses10.0M13.6M13.9M11.2M12.9M6.9M
Operating Income(10.0M)(13.1M)(13.9M)(11.0M)(9.9M)(9.4M)
Ebit(10.1M)(13.1M)(13.8M)(11.0M)(9.9M)(9.4M)
Ebitda(10.0M)(13.1M)(13.7M)(11.0M)(9.9M)(9.4M)
Total Operating Expenses10.0M13.3M13.9M11.1M12.7M6.6M
Net Income(10.1M)(12.9M)(13.5M)(9.8M)(8.8M)(9.3M)
Income Tax Expense40.2K(181.3K)(280K)(119K)(136.9K)(130.0K)
Depreciation And Amortization90.2K59.9K42K46K52.9K50.3K
Income Before Tax(10.1M)(13.1M)(13.8M)(9.9M)(8.9M)(9.4M)
Total Other Income Expense Net(114.2K)7.7K104K1.1M972.9K1.0M
Research Development4.4M6.2M6.7M4.8M5.5M3.6M
Cost Of Revenue90.2K385.0K42K161K185.2K175.9K
Net Income From Continuing Ops(9.9M)(13.1M)(13.8M)(9.9M)(8.9M)(9.4M)
Non Operating Income Net Other46.0K71.4K33.9K104K119.6K125.6K
Net Income Applicable To Common Shares(11.6M)(10.0M)(13.0M)(13.6M)(12.2M)(12.8M)
Interest Income33.9K2.3K104K1.1M1.2M1.3M
Minority Interest(74.0K)173.5K(176K)119K136.9K143.7K
Net Interest Income33.9K2.3K104K1.1M1.2M1.3M
Reconciled Depreciation90.2K59.9K42K46K41.4K39.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.